J McConn - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J McConn

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 24, 2004

Evidence of significant contribution from CYP3A5 to hepatic drug metabolismWeili Huang, Yvonne S Lin, Donavon J McConn, et al.

Clinical Pharmacology and Therapeutics|February 13, 2009

Reduced duodenal cytochrome P450 3A protein expression and catalytic activity in patients with cirrhosisD J McConn, Y S Lin, T L Mathisen, et al.

Journal of Medicinal Chemistry|July 14, 2021

Discovery of TAK-041: a Potent and Selective GPR139 Agonist Explored for the Treatment of Negative Symptoms Associated with SchizophreniaHolly A Reichard, Hans H Schiffer, Holger Monenschein, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 24, 2004

Evidence of significant contribution from CYP3A5 to hepatic drug metabolismWeili Huang, Yvonne S Lin, Donavon J McConn, et al.

Clinical Pharmacology and Therapeutics|February 13, 2009

Reduced duodenal cytochrome P450 3A protein expression and catalytic activity in patients with cirrhosisD J McConn, Y S Lin, T L Mathisen, et al.

Journal of Medicinal Chemistry|July 14, 2021

Discovery of TAK-041: a Potent and Selective GPR139 Agonist Explored for the Treatment of Negative Symptoms Associated with SchizophreniaHolly A Reichard, Hans H Schiffer, Holger Monenschein, et al.

Pageof 2